Show simple item record

Endocrine tumours of the pancreas: Review and recent advances

dc.contributor.authorMullan, Michelle H.en_US
dc.contributor.authorGauger, Paul G.en_US
dc.contributor.authorThompson, Norman W.en_US
dc.date.accessioned2010-06-01T22:04:50Z
dc.date.available2010-06-01T22:04:50Z
dc.date.issued2001-08-04en_US
dc.identifier.citationMullan, Michelle H.; Gauger, Paul G.; Thompson, Norman W. (2001). "Endocrine tumours of the pancreas: Review and recent advances." ANZ Journal of Surgery 71(8): 475-482. <http://hdl.handle.net/2027.42/75105>en_US
dc.identifier.issn1445-1433en_US
dc.identifier.issn1445-2197en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75105
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11504292&dopt=citationen_US
dc.format.extent905741 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ptyen_US
dc.rightsRoyal Australasian College of Surgeonsen_US
dc.subject.otherEndoscopic Ultrasounden_US
dc.subject.otherMultiple Endocrine Neoplasia-1en_US
dc.subject.otherPancreatic Endocrine Tumoursen_US
dc.subject.otherReviewen_US
dc.subject.otherSomatostatin Receptor Scintigraphyen_US
dc.titleEndocrine tumours of the pancreas: Review and recent advancesen_US
dc.typeArticleen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery, Division of Endocrine Surgery, University of Michigan Hospital, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid11504292en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75105/1/j.1440-1622.2001.02191.x.pdf
dc.identifier.doi10.1046/j.1440-1622.2001.02191.xen_US
dc.identifier.sourceANZ Journal of Surgeryen_US
dc.identifier.citedreferenceWilder RM, Allan FN, Power MH et al. Carcinoma of the islets of the pancreas: Hyperinsulinism and hypoglycemia. JAMA 1927; 89: 348 – 55.en_US
dc.identifier.citedreferenceWhipple AO & Franz VK. Adenoma of islet cells with hyperinsulinism. Am. Surg. 1935; 101: 1299 – 935.en_US
dc.identifier.citedreferenceGrant CS. Gastrointestinal endocrine tumours. Insulinoma. Baillieres Clin. Gastroenterol. 1996; 10: 645 – 71.en_US
dc.identifier.citedreferenceProye C, Pattou F, Carnaille B et al. Intraoperative insulin measurement during surgical management of insulinomas. World J. Surg. 1998; 22: 1218 – 24.en_US
dc.identifier.citedreferenceFong TL, Warner NE, Kumar D. Pancreatic nesidioblastosis in adults. Diabetes Care 1989; 12: 108 – 14.en_US
dc.identifier.citedreferenceZollinger RM & Ellison EH. Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg. 1955; 142: 709 – 23.en_US
dc.identifier.citedreferenceGregory RA, Tracy HJ, French JM et al. Extraction of a gastrin-like substance from a pancreatic tumor in a case of Zollinger– Ellison syndrome. Lancet 1960; 1: 1045 – 8.en_US
dc.identifier.citedreferenceThompson NW, Vinik AI, Eckhauser FE. Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger– Ellison syndrome. Ann. Surg. 1989; 209: 396 – 404.en_US
dc.identifier.citedreferenceThompson NW, Pasieka J, Fukuuchi A. Duodenal gastrinomas, duodenotomy and duodenal exploration in the surgical management of Zollinger–Ellison syndrome. World J. Surg. 1993; 17: 455 – 62.en_US
dc.identifier.citedreferencePrinz RA, Badrinath K, Banerji M et al. Operative and chemotheraputic management of malignant producing tumors. Surgery 1981; 90: 713 – 19.en_US
dc.identifier.citedreferenceWiedenmann B, Jensen RT, Mignon M et al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumours: General recommendations by a consensus workshop. World J. Surg. 1998; 22: 309 – 18.en_US
dc.identifier.citedreferenceRothmund M, Stinner B, Arnold R. Endocrine pancreatic carcinoma. Eur. J. Surg. Oncol. 1991; 17: 191 – 9.en_US
dc.identifier.citedreferenceBieligk S & Jaffe BM. Islet cell tumors of the pancreas. Surg. Clin. North Am. 1995; 75: 1025 – 40.en_US
dc.identifier.citedreferenceReynolds C, Pratt R, Chan-Yan C. Somatostatinoma: The most recently described pancreatic islet cell tumor. West. J. Med. 1985; 142: 393 – 7.en_US
dc.identifier.citedreferenceMaton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analog SMS201-995 in patients with pancreatic islet cell tumors. Dig. Dis. Sci. 1989; 34: S28 – S39.en_US
dc.identifier.citedreferenceDeclore R & Friesen SR. Gastrointestinal neuroendocrine tumors. J. Am. Coll Surg. 1994; 178: 187 – 211.en_US
dc.identifier.citedreferenceMozell E, Stenzel P, Woltering E et al. Functional endocrine tumors of the pancreas: Clinical presentation, diagnosis, and treatment. Curr. Probl. Surg. 1990; 27: 303 – 86.en_US
dc.identifier.citedreferenceMoertel CG, Hanley JA, Johnson LA. Streptozotocin alone compared with streptozotocin plus 5-fluorouracil in the treatment of advanced islet cell carcinoma. N. Engl. J. Med. 1980; 303: 1189 – 94.en_US
dc.identifier.citedreferenceEriksson B, Oberg K, Alan G et al. Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. Lancet 1986; 2: 1307 – 9.en_US
dc.identifier.citedreferenceJensen RT. Pancreatic endocrine tumors: Recent advances. Ann. Oncol. 1999; 10: S170 – S176.en_US
dc.identifier.citedreferenceChandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997; 276: 404 – 6.en_US
dc.identifier.citedreferenceThompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the MEN type1 patient. J. Intern. Med. 1995; 238: 269 – 80.en_US
dc.identifier.citedreferenceTeh BT. Thymic carcinoids in multiple endocrine neoplasia type 1. J. Intern. Med. 1998; 243: 501 – 4.en_US
dc.identifier.citedreferencevan Heerden JA, Smith SL, Miller LJ. Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1. Surgery 1986; 100: 971 – 6.en_US
dc.identifier.citedreferenceMignon M, Ruszniewski P, Podevin P et al. Current approach to the management of a gastrinoma and insulinoma in adults with multiple endocrine neoplasia I. World J. Surg. 1993; 17: 489 – 97.en_US
dc.identifier.citedreferenceThompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic duodenal disease. Results in the treatment of 40 patients with Zollinger– Ellison syndrome, hypoglycaemia or both. J. Intern. Med. 1998; 243: 495 – 500.en_US
dc.identifier.citedreferenceMoore NR, Rogers CE, Britton BJ. Magnetic resonance imaging of endocrine tumours of the pancreas. Br. J. Radiol. 1995; 68: 341 – 7.en_US
dc.identifier.citedreferenceCatalano C, Pavone P, Laghi A et al. Localization of pancreatic insulinomas with MR imaging at 0.5T. Acta Radiol. 1999; 40: 644 – 8.en_US
dc.identifier.citedreferenceGibril F, Reynolds JC, Doppman JL et al. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: A prospective study. Ann. Intern. Med. 1996; 125: 26 – 34.en_US
dc.identifier.citedreferenceKrenning EP, Kwekkeboom DJ, Bakker WH et al. Somatostatin receptor scintigraphy with [ 111 In-DTPA-D-Phe 1 ]- and [ 123 I-Tyr 3 ]-octreotide: The Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 1993; 20: 716 – 31.en_US
dc.identifier.citedreferenceNorton JA, Fraker DL, Alexander HR et al. Surgery to cure Zollinger–Ellison syndrome. N. Engl. J. Med. 1999; 341: 635 – 44.en_US
dc.identifier.citedreferenceZimmer T, StÖlzer U, BÄder M et al. Endoscopic ultrasonography and somatotstatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 1996; 39: 562 – 8.en_US
dc.identifier.citedreferenceRÖsch T, Lightdale CJ, Botet JF et al. Localization of pancreatic endocrine tumors by endoscopic ultrasound. N. Engl. J. Med. 1992; 326: 1721 – 6.en_US
dc.identifier.citedreferenceThompson NW, Czako PF, Fritts LL et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 1994; 116: 1131 – 8.en_US
dc.identifier.citedreferenceProye C, Malvaux P, Pattou F et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery 1998; 124: 1134 – 44.en_US
dc.identifier.citedreferenceRothmund M. Localization of endocrine pancreatic tumours. Br. J. Surg. 1994; 81: 164 – 6.en_US
dc.identifier.citedreferenceLo CY, Lam KY, Kung AW et al. Pancreatic insulinomas: A 15 year experience. Arch. Surg. 1997; 132: 926 – 30.en_US
dc.identifier.citedreferenceDoppman JL. Pancreatic endocrine tumors: The search goes on. N. Engl. J. Med. 1992; 326: 1770 – 2.en_US
dc.identifier.citedreferenceLo CY, Chan FL, Tam SCF et al. Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 2000; 128: 903 – 9.en_US
dc.identifier.citedreferenceDoherty GM, Doppman JL, Shawker TH et al. Results of a prospective strategy to diagnose, localize, and resect insulinoma. Surgery 1992; 110: 989 – 97.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.